MDNA Medicenna Therapeutics Corp.

0.1224USD0.1750 CAD · TSX-20.45%Mkt Cap: 11.30M USDP/E: —

Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated…

Institutional holders2 on file

Key Statistics

Company
Market Cap11.30M USD
Enterprise Value10.94M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-12.87M USD
Revenue/Share—
Last Price0.1224 USD
Fiscal Year EndMar 2026
MR QuarterJun 2026
Employees15
CountryCA
SectorHealthcare
IndustryBiotechnology
ISINCA58490H1073
Valuation
P/E (Trailing)—
P/E (Forward)-0.76
PEG—
EV/EBITDA-0.70
EV/Revenue—
P/S—
P/B5.83
EPS (TTM)-0.15 USD
EPS (Forward)-0.16 USD
52W Range
0.11890% of range1.245
52W High1.245 USD
52W Low0.1189 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-741.70%
ROA-217.75%
ROIC—
ROCE-749.98%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-12.53M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-66.82%
Net Debt-3.91M USD
Net Debt/EBITDA0.25
Net Debt/FCF—
Balance Sheet
Debt/Equity0.05
Current Ratio1.25
Quick Ratio1.11
Book Value/Sh0.02 USD
Cash/Share0.04 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateMar 3, 2017
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)1.958 USD
Upside (mean)+1500.0%
Target Range1.119 USD – 2.797 USD
1.119+1500.0% to mean2.797
# Analysts2
Ownership
Shares Out.92.30M
Float74.34M
Insiders18.82%
Institutions0.00%
Short Interest
Short Ratio2.0d
Short % Float0.33%
Short % Out.0.14%
Shares Short126.49K
Short (prev mo.)124.24K
Technical
SMA 500.2834 (-56.8%)
SMA 2000.3615 (-66.1%)
Beta2.21
S&P 52W Chg8.68%
Avg Vol (30d)105.02K
Avg Vol (10d)176.30K
Technical Indicators
RSI (14)27.1
MACD-0.0536
MACD Signal-0.0257
MACD Hist.-0.0278
BB Upper0.3975 USD
BB Middle0.2643 USD
BB Lower0.1311 USD
BB Width100.79%
ATR (14)0.0329 USD
Vol Ratio (20d)3.90x

About Medicenna Therapeutics (TSE: MDNA)

›

Medicenna Therapeutics (TSE: MDNA) is listed on the Toronto Stock Exchange, where its shares trade in CAD. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 15 employees.

The shares were at 0.1750 CAD on 20 November 2026, down 88.3% over 52 weeks. Its 52-week range is 0.1700 CAD to 1.780 CAD: the price is 90.2% below the high and 2.9% above the low.

Its market capitalisation is 16.15M CAD.

Medicenna Therapeutics reports an operating margin of 0.0%.

It holds more cash than debt, a net cash position of 5.59M CAD. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health.